Advanced Neuromodulation Systems, Inc. (ANS), the company sponsoring this clinical research study, is the technology leader in implantable neurostimulation therapies, with nearly 20 years of experience, numerous technological firsts, and more than 25,000 patients in over 25 countries with ANS devices used for chronic pain management. ANS’ goal is to improve the lives of the millions of people around the world who suffer with disabling pain or nervous system disorders. To learn more about ANS, visit www.sjmneuro.com.

In 2005, ANS became a St. Jude Medical company. St. Jude Medical is a leading manufacturer of cardiac pacemakers, implantable defibrillators, and heart valves. Over 1 million mothers, fathers, grandparents, and children worldwide have received a life-saving St. Jude Medical device. To learn more about St. Jude Medical, visit www.sjm.com.